INTERNATIONAL MUREX TECHNOLOGIES CORPORATION
COMPUTATIONS OF EARNINGS PER SHARE (1)
THREE MONTHS ENDED NINE MONTHS ENDED
SEPTEMBER 30, SEPTEMBER 30,
---------------------- --------------------
1997 1996 1997 1996
---------- -------- --------- --------
PRIMARY
Weighted average shares outstanding
during the period 16,510 16,168 16,460 16,164
Shares issuable upon assumed exercise
of stock options and warrants, less
amounts assumed repurchased under
treasury stock method(2) 1,269 279 1,221 93
---------- -------- --------- --------
Total common shares and common
shares equivalents 17,779 16,447 17,681 16,257
========== ======== ========= ========
Net income (loss) $2,565 $1,292 $6,313 $9
========== ======== ========= ========
Primary per share amount $0.14 $0.08 $0.36 $0.00
========== ======== ========= ========
FULLY DILUTED(3)
Total common shares and common
share equivalents 17,779 16,447 17,681 16,257
Additional shares issuable upon
assumed exercise of stock options
and warrants, less amounts assumed
repurchased under treasury stock
method(2) 53 395 93 132
---------- -------- --------- --------
Total 17,832 16,842 17,774 16,389
========== ======== ========= ========
Net income (loss) $2,565 $1,292 $6,313 $9
========== ======== ========= ========
Fully diluted per share amount $0.14 $0.08 $0.36 $0.00
========== ======== ========= ========
(1) Weighted average share and dollar amounts, except per share
amounts, are stated in thousands
(2) Shares issued from assumed exercise of options and warrants
include the number of incremental shares which result from
applying the "treasury stock method" for options and warrants,
APB Opinion No. 15, paragraph 36. The options and warrants are
antidilutive in 1995 and are not included in the calculation.
(3) This calculation is submitted in accordance with 17 CFR
229.601(b)(11) although not required by APB Opinion No. 15
because it results in dilution of less than 3%.
-21-